Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 944

1.

Red blood cell distribution width is a simple and novel biomarker for survival in light-chain amyloidosis.

Yogo T, Okazuka K, Nashimoto J, Uto Y, Sato K, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Tsukada N, Ishida T, Suzuki K.

Int J Hematol. 2019 Jun 24. doi: 10.1007/s12185-019-02692-0. [Epub ahead of print]

PMID:
31236823
2.

Familial Hypercholesterolemia and Lipoprotein Apheresis.

Makino H, Koezuka R, Tamanaha T, Ogura M, Matsuki K, Hosoda K, Harada-Shiba M.

J Atheroscler Thromb. 2019 Jun 22. doi: 10.5551/jat.RV17033. [Epub ahead of print]

3.

Factors associated with functional rehabilitation outcomes of non-operative treatment for hip fractures: a retrospective study.

Nakamura K, Nakajo A, Nagasawa Y, Asakura E, Sasaki T, Ogura M, Hagiwara S, Takahashi A, Kozaka N, Hosaka M.

J Phys Ther Sci. 2019 May;31(5):453-456. doi: 10.1589/jpts.31.453. Epub 2019 May 10.

4.
5.

Arteritis after administration of granulocyte colony-stimulating factor: a case series.

Sasaki K, Miyauchi M, Ogura M, Shimura-Nukina A, Toyama K, Nakazaki K, Watadani T, Abe O, Kurokawa M.

Int J Hematol. 2019 May 14. doi: 10.1007/s12185-019-02662-6. [Epub ahead of print]

PMID:
31090035
6.

Successful treatment of esophagopleural fistula following pulmonary resection for primary lung cancer: a case report.

Eguchi K, Ogura M, Hisaoka K, Bekku E, Suda S, Shimogawara T, Kadota Y, Ono S, Asahara F, Takigawa Y, Wada N, Hasegawa H, Matsui J.

Surg Case Rep. 2019 May 14;5(1):78. doi: 10.1186/s40792-019-0638-1.

7.

[Efficacy of plerixafor in autologous peripheral blood stem cell collection].

Yogo T, Tsukada N, Nashimoto J, Uto Y, Sato K, Miyazaki K, Ogura M, Yoshiki Y, Abe Y, Okazuka K, Ishida T, Suzuki K.

Rinsho Ketsueki. 2019;60(3):165-170. doi: 10.11406/rinketsu.60.165. Japanese.

PMID:
31068511
8.

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.

Suzuki T, Shinozaki E, Osumi H, Nakayama I, Ota Y, Ichimura T, Ogura M, Wakatsuki T, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Chemother Pharmacol. 2019 Aug;84(2):307-313. doi: 10.1007/s00280-019-03855-w. Epub 2019 May 7.

PMID:
31065729
9.

Plant complex type free N-glycans occur in tomato xylem sap.

Tsujimori Y, Ogura M, Rahman MZ, Maeda M, Kimura Y.

Biosci Biotechnol Biochem. 2019 Jul;83(7):1310-1314. doi: 10.1080/09168451.2019.1608803. Epub 2019 Apr 25.

PMID:
31021709
10.

Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.

Osumi H, Shinozaki E, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Takahari D, Ooki A, Suzuki T, Ota Y, Nakayama I, Chin K, Miki Y, Yamaguchi K.

Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32320. [Epub ahead of print]

PMID:
30963570
11.

Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys-Drash syndrome and congenital nephrotic syndrome of the Finnish type.

Nishi K, Inoguchi T, Kamei K, Hamada R, Hataya H, Ogura M, Sato M, Yoshioka T, Ogata K, Ito S, Nakanishi K, Nozu K, Hamasaki Y, Ishikura K.

Clin Exp Nephrol. 2019 Aug;23(8):1058-1065. doi: 10.1007/s10157-019-01732-7. Epub 2019 Apr 8.

PMID:
30963316
12.

Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution.

Ishiwa S, Sato M, Morisada N, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Kosuga M, Kamei K, Ito S, Nozu K, Iijima K, Ishikura K.

Pediatr Nephrol. 2019 Aug;34(8):1457-1464. doi: 10.1007/s00467-019-04230-w. Epub 2019 Apr 1.

PMID:
30937553
13.

Development of Imidazo[1,2- a]pyridine Derivatives with an Intramolecular Hydrogen-Bonded Seven-Membered Ring Exhibiting Bright ESIPT Luminescence in the Solid State.

Mutai T, Muramatsu T, Yoshikawa I, Houjou H, Ogura M.

Org Lett. 2019 Apr 5;21(7):2143-2146. doi: 10.1021/acs.orglett.9b00455. Epub 2019 Mar 28.

PMID:
30920228
14.

A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma.

Ohmachi K, Ogura M, Suehiro Y, Ando K, Uchida T, Choi I, Ogawa Y, Kobayashi M, Fukino K, Yokoi Y, Okamura J.

Int J Hematol. 2019 Jun;109(6):657-664. doi: 10.1007/s12185-019-02635-9. Epub 2019 Mar 26.

PMID:
30915717
15.

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.

Suenaga M, Wakatsuki T, Mashima T, Ogura M, Ichimura T, Shinozaki E, Nakayama I, Osumi H, Ota Y, Takahari D, Chin K, Seimiya H, Yamaguchi K.

Invest New Drugs. 2019 Mar 6. doi: 10.1007/s10637-019-00749-9. [Epub ahead of print]

PMID:
30838483
16.

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.

Hatsumi N, Miyawaki S, Yamauchi T, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Machida S, Nishii K, Honda S, Ohnishi K, Naoe T; Japan Adult Leukemia Study Group (JALSG).

Int J Hematol. 2019 Apr;109(4):418-425. doi: 10.1007/s12185-019-02606-0. Epub 2019 Feb 6.

PMID:
30725360
17.

Algal Protein Kinase, Triacylglycerol Accumulation Regulator 1, Modulates Cell Viability and Gametogenesis in Carbon/Nitrogen-Imbalanced Conditions.

Shinkawa H, Kajikawa M, Nomura Y, Ogura M, Sawaragi Y, Yamano T, Nakagami H, Sugiyama N, Ishihama Y, Kanesaki Y, Yoshikawa H, Fukuzawa H.

Plant Cell Physiol. 2019 Apr 1;60(4):916-930. doi: 10.1093/pcp/pcz010.

PMID:
30668822
18.

Biopsy-based estimation of total nephron number in Japanese living kidney donors.

Sasaki T, Tsuboi N, Kanzaki G, Haruhara K, Okabayashi Y, Koike K, Kobayashi A, Yamamoto I, Ogura M, Hoy WE, Bertram JF, Shimizu A, Yokoo T.

Clin Exp Nephrol. 2019 May;23(5):629-637. doi: 10.1007/s10157-018-01686-2. Epub 2019 Jan 12.

PMID:
30635748
19.

Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report.

Saida K, Kamei K, Ogura M, Matsumura S, Kano Y, Sato M, Andoh A, Ishikura K.

Transplant Proc. 2018 Dec;50(10):3925-3927. doi: 10.1016/j.transproceed.2018.04.039. Epub 2018 Apr 18.

PMID:
30577288
20.

Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?

Saida K, Ogura M, Kano Y, Ishimori S, Yoshikawa T, Nagata H, Sato M, Kamei K, Ishikura K.

BMC Nephrol. 2018 Dec 17;19(1):365. doi: 10.1186/s12882-018-1168-y.

21.

Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV.

Okabayashi Y, Tsuboi N, Haruhara K, Kanzaki G, Koike K, Miyazaki Y, Kawamura T, Ogura M, Yokoo T.

Mod Rheumatol. 2018 Dec 17:1-7. doi: 10.1080/14397595.2018.1558948. [Epub ahead of print]

PMID:
30557058
22.

The relationship between the houseboundedness and frailty of community-dwelling elderly persons.

Katsura T, Abe N, Komata M, Ogura M, Ishikawa N, Hoshino A, Shizawa M, Usui K, Yokoyama E, Hara M.

J Rural Med. 2018 Nov;13(2):141-150. doi: 10.2185/jrm.2972. Epub 2018 Nov 29.

23.

Evaluating the Effectiveness and Safety of the Electroencephalogram-Based Brain-Machine Interface Rehabilitation System for Patients With Severe Hemiparetic Stroke: Protocol for a Randomized Controlled Trial (BEST-BRAIN Trial).

Mizuno K, Abe T, Ushiba J, Kawakami M, Ohwa T, Hagimura K, Ogura M, Okuyama K, Fujiwara T, Liu M.

JMIR Res Protoc. 2018 Dec 6;7(12):e12339. doi: 10.2196/12339.

24.

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake.

Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K.

Onco Targets Ther. 2018 Nov 23;11:8301-8307. doi: 10.2147/OTT.S184665. eCollection 2018.

25.

Early neurosyphilis presenting with multiple cranial nerve palsies: A case report of management by combined penicillin-corticosteroid treatment.

Komamura H, Nakamura T, Kobayashi J, Harada R, Endo K, Ogura M, Higuchi J.

J Infect Chemother. 2019 May;25(5):362-364. doi: 10.1016/j.jiac.2018.11.007. Epub 2018 Dec 8.

PMID:
30538059
26.

Favorable kidney function in pediatric liver transplant recipients: results of a single-center cohort study.

Sato M, Kaneko T, Ogura M, Kamei K, Ito S, Fukuda A, Sakamoto S, Kasahara M, Ishikura K.

Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002548. [Epub ahead of print]

PMID:
30489480
27.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):526. doi: 10.1007/s10120-018-0900-4.

28.

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer.

Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K.

Cancer Manag Res. 2018 Nov 1;10:5283-5290. doi: 10.2147/CMAR.S179219. eCollection 2018.

29.

No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.

Kiuchi Z, Ogura M, Sato M, Kamei K, Ishikura K, Abe J, Ito S.

Scand J Rheumatol. 2019 May;48(3):246-248. doi: 10.1080/03009742.2018.1493745. Epub 2018 Nov 8. No abstract available.

PMID:
30406708
30.

Cross-cultural, population-based study on adolescent body image and eating distress in Japan and Finland.

Maezono J, Hamada S, Sillanmäki L, Kaneko H, Ogura M, Lempinen L, Sourander A.

Scand J Psychol. 2019 Feb;60(1):67-76. doi: 10.1111/sjop.12485. Epub 2018 Nov 5.

PMID:
30395688
31.

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.

Ogura M, Sancho JM, Cho SG, Nakazawa H, Suzumiya J, Tumyan G, Kim JS, Lennard A, Mariz J, Ilyin N, Jurczak W, Lopez Martinez A, Samoilova O, Zhavrid E, Yañez Ruiz E, Trneny M, Popplewell L, Coiffier B, Buske C, Kim WS, Lee SJ, Lee SY, Bae YJ, Kwak LW.

Lancet Haematol. 2018 Nov;5(11):e543-e553. doi: 10.1016/S2352-3026(18)30157-1.

PMID:
30389036
32.

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.

Watanabe T, Tobinai K, Wakabayashi M, Morishima Y, Kobayashi H, Kinoshita T, Suzuki T, Yamaguchi M, Ando K, Ogura M, Taniwaki M, Uike N, Yoshino T, Nawano S, Terauchi T, Hotta T, Nagai H, Tsukasaki K; JCOG0203 Collaborators.

Lancet Haematol. 2018 Nov;5(11):e520-e531. doi: 10.1016/S2352-3026(18)30155-8.

PMID:
30389034
33.

Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study.

Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M, Narita I, Ninomiya T, Yokoyama H, Yokoo T.

BMJ Open. 2018 Oct 31;8(10):e024317. doi: 10.1136/bmjopen-2018-024317.

34.

A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity.

Okonogi H, Kawamura T, Joh K, Koike K, Miyazaki Y, Ogura M, Tsuboi N, Hirano K, Matsushima M, Yokoo T, Horikoshi S, Suzuki Y, Yasuda T, Shirai S, Shibata T, Hattori M, Akioka Y, Katafuchi R, Hashiguchi A, Hisano S, Shimizu A, Kimura K, Maruyama S, Matsuo S, Tomino Y; Special IgA Nephropathy Study Group.

Clin Exp Nephrol. 2019 Jan;23(1):16-25. doi: 10.1007/s10157-018-1657-0. Epub 2018 Oct 26. Review.

35.

A Case of Hepatic Glomerulosclerosis with Monoclonal IgA1-κ Deposits.

Okabayashi Y, Tsuboi N, Nakaosa N, Haruhara K, Kanzaki G, Koike K, Shimizu A, Fukui A, Okonogi H, Miyazaki Y, Kawamura T, Ogura M, Shimizu A, Yokoo T.

Case Rep Nephrol. 2018 Oct 1;2018:4748357. doi: 10.1155/2018/4748357. eCollection 2018.

36.

Volume Ratio of Glomerular Tufts to Bowman Capsules and Renal Outcomes in Nephrosclerosis.

Haruhara K, Tsuboi N, Sasaki T, Amano H, Tanaka M, Koike K, Kanzaki G, Okabayashi Y, Miyazaki Y, Ogura M, Yokoo T.

Am J Hypertens. 2019 Jan 1;32(1):45-53. doi: 10.1093/ajh/hpy147.

PMID:
30358804
37.

Newly Identified Nucleoid-Associated-Like Protein YlxR Regulates Metabolic Gene Expression in Bacillus subtilis.

Ogura M, Kanesaki Y.

mSphere. 2018 Oct 24;3(5). pii: e00501-18. doi: 10.1128/mSphere.00501-18.

38.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):518-525. doi: 10.1007/s10120-018-0887-x. Epub 2018 Oct 17. Erratum in: Gastric Cancer. 2018 Nov 22;:.

39.

Effect of the combination of motor imagery and electrical stimulation on upper extremity motor function in patients with chronic stroke: preliminary results.

Okuyama K, Ogura M, Kawakami M, Tsujimoto K, Okada K, Miwa K, Takahashi Y, Abe K, Tanabe S, Yamaguchi T, Liu M.

Ther Adv Neurol Disord. 2018 Oct 9;11:1756286418804785. doi: 10.1177/1756286418804785. eCollection 2018.

40.

Prenylated quinolinecarboxylic acid derivative prevents neuronal cell death through inhibition of MKK4.

Ogura M, Kikuchi H, Shakespear N, Suzuki T, Yamaki J, Homma MK, Oshima Y, Homma Y.

Biochem Pharmacol. 2019 Apr;162:109-122. doi: 10.1016/j.bcp.2018.10.008. Epub 2018 Oct 12.

PMID:
30316820
41.

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab.

Ushida Y, Shinozaki E, Chin K, Suenaga M, Takahari D, Ozaka M, Ogura M, Ichimura T, Wakatsuki T, Yamaguchi K.

Case Rep Oncol. 2018 Aug 29;11(2):601-608. doi: 10.1159/000492568. eCollection 2018 May-Aug.

42.

Necessity of performing voiding cystourethrography for children with unilateral multicystic dysplastic kidney.

Yamamoto K, Kamei K, Sato M, Ogura M, Suzuki M, Hasegawa Y, Ueoka K, Ito S, Ishikura K.

Pediatr Nephrol. 2019 Feb;34(2):295-299. doi: 10.1007/s00467-018-4079-z. Epub 2018 Sep 25.

PMID:
30255447
43.

Farming habit, light exposure, physical activity, and depressive symptoms. A cross-sectional study of the HEIJO-KYO cohort.

Asai Y, Obayashi K, Oume M, Ogura M, Takeuchi K, Yamagami Y, Tai Y, Kurumatani N, Saeki K.

J Affect Disord. 2018 Dec 1;241:235-240. doi: 10.1016/j.jad.2018.08.003. Epub 2018 Aug 10.

PMID:
30138807
44.

Clinical and Pathological Characteristics of Elderly Japanese Patients with IgA Vasculitis with Nephritis: A Case Series.

Ueda H, Miyazaki Y, Tsuboi N, Hirano K, Yokote S, Kobayashi E, Ogura M, Kawamura T, Ryuzaki M, Yokoo T.

Intern Med. 2019 Jan 1;58(1):31-38. doi: 10.2169/internalmedicine.1379-18. Epub 2018 Aug 10.

45.

Hypoglycemia Unawareness in Insulinoma Revealed with Flash Glucose Monitoring Systems.

Sugawa T, Murakami T, Yabe D, Kashima R, Tatsumi M, Ooshima S, Joo E, Wada K, Yoshizawa A, Masui T, Nakamoto Y, Yamauchi Y, Kodama Y, Iemura Y, Ogura M, Yasoda A, Inagaki N.

Intern Med. 2018 Dec 1;57(23):3407-3412. doi: 10.2169/internalmedicine.1173-18. Epub 2018 Aug 10.

46.

Protein hypoacylation induced by Sirt5 overexpression has minimal metabolic effect in mice.

Bentley NL, Fiveash CE, Osborne B, Quek LE, Ogura M, Inagaki N, Cooney GJ, Polly P, Montgomery MK, Turner N.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1349-1355. doi: 10.1016/j.bbrc.2018.07.047. Epub 2018 Jul 13.

PMID:
30017194
47.

Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Nov;103(11):1815-1824. doi: 10.3324/haematol.2018.190728. Epub 2018 Jul 5.

48.

R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.

Ogura M, Yamamoto K, Morishima Y, Wakabayashi M, Tobinai K, Ando K, Uike N, Kurosawa M, Gomyo H, Taniwaki M, Nosaka K, Tsukamoto N, Shimoyama T, Fukuhara N, Yakushijin Y, Ohnishi K, Miyazaki K, Sawada K, Takayama N, Hanamura I, Nagai H, Kobayashi H, Usuki K, Kobayashi N, Ohyashiki K, Utsumi T, Kumagai K, Maruyama D, Ohmachi K, Matsuno Y, Nakamura S, Hotta T, Tsukasaki K; Japan Clinical Oncology Group- Lymphoma Study Group (JCOG-LSG).

Cancer Sci. 2018 Sep;109(9):2830-2840. doi: 10.1111/cas.13719. Epub 2018 Jul 28.

49.

Esophageal carcinosarcoma comprised of minimally invasive squamous cell carcinoma and undifferentiated pleomorphic sarcoma: A collision cancer?

Miyauchi J, Ogura M, Sato M, Matsui J.

Pathol Int. 2018 Jun 22. doi: 10.1111/pin.12689. [Epub ahead of print]

PMID:
29934989
50.

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.

Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K.

Cancer Sci. 2018 Aug;109(8):2567-2575. doi: 10.1111/cas.13698. Epub 2018 Jul 13.

Supplemental Content

Support Center